Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase
about
In vitro activity of biapenem (L-627), a new carbapenem, against anaerobesBeta-lactamase inhibitors from laboratory to clinicCarbapenems: past, present, and futureThe renal membrane dipeptidase (dehydropeptidase I) inhibitor, cilastatin, inhibits the bacterial metallo-beta-lactamase enzyme CphAAntibacterial natural products in medicinal chemistry--exodus or revival?Repurposing clinically approved cephalosporins for tuberculosis therapyPopulation pharmacokinetics of meropenem during continuous infusion in surgical ICU patients.Prediction of human pharmacokinetics of panipenem-betamipron, a new carbapenem, from animal data.In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345).cDNA cloning and expression in Xenopus laevis oocytes of pig renal dipeptidase, a glycosyl-phosphatidylinositol-anchored ectoenzymeEffects of cilastatin on the pharmacokinetics of a new carbapenem, DA-1131, in rats, rabbits, and dogs.Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.Stability of new carbapenem DA-1131 to renal dipeptidase (dehydropeptidase I).Hydrolysis of S-aryl-cysteinylglycine conjugates catalyzed by porcine kidney cortex membrane dipeptidase.Recent developments in carbapenems.The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.Interactions of biapenem with active-site serine and metallo-beta-lactamases.Chemistry of newer antibiotics directed toward overcoming bacterial resistancePharmacokinetics of L-749,345, a long-acting carbapenem antibiotic, in primates.Multicenter in vitro evaluation of SM-7338, a new carbapenem.Therapeutic effects of imipenem-cilastatin on experimental intrauterine infections in rats.Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infectionsImipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.Safety and efficacy of high-dose treatment with imipenem-cilastatin in seriously ill patients.In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepaciaCombinations of β-Lactam Antibiotics Currently in Clinical Trials Are Efficacious in a DHP-I-Deficient Mouse Model of Tuberculosis InfectionIn vitro activity and beta-lactamase stability of LJC 10,627Pharmacokinetics of meropenem in subjects with various degrees of renal impairmentCarbapenems in the USA: focus on doripenem.Effects of water deprivation on drug pharmacokinetics: correlation between drug metabolism and hepatic CYP isozymes.Comprehensive Proteomic Characterization of the Human Colorectal Carcinoma Reveals Signature Proteins and Perturbed Pathways.Molecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs.Biotransformation and bioactivation reactions of alicyclic amines in drug molecules.Characterization of beta-lactamases.β-Lactams and β-Lactamase Inhibitors: An Overview.In vitro and pharmacokinetic properties of the carbapenems.Peptides and related drugs: a review of their absorption, metabolism, and excretion.In vitro and in vivo antibacterial activities of BO-2727, a new carbapenemIn vitro antibacterial activity and beta-lactamase stability of a new carbapenem, BO-2727.Pharmacokinetics in nonhuman primates of a prototype carbapenem active against methicillin-resistant Staphylococcus aureus.
P2860
Q24613554-ADDCC5BB-7A19-4FE0-AF0A-596AF9786497Q24617277-C31D9F87-3C79-487D-B905-A2B98A59FAF3Q24634999-DA2611C0-AD78-43E4-811E-8040454B9E2CQ24676934-E939B6D0-96A4-4838-9D21-EFB019C1E517Q28255204-707A79B4-C9F4-49A2-9993-51DAA169F8A2Q28828720-40AFCA2B-77AC-467F-8D08-E30E066006C7Q30316322-3FC9BEF0-5F7D-4F40-A97C-82D1AF6EADDCQ30868180-361BCD0C-7C2F-4D5B-B277-5946FF4E0752Q33694847-5BDB8A1C-4A30-42B5-B89B-2A5957C887F1Q33955479-851A71F3-524E-4702-A077-CDF9E81A2F85Q33977909-05A42D34-27AF-4DAD-8DE7-7D9E55F64C9DQ33978241-C0E556A9-28CF-4B6D-8C1E-6A4922CAE932Q34105432-BE1ABACD-E27C-416E-9E27-3470304F9522Q34320176-C270A2C5-4250-4748-ACC1-B87D2BF5CA05Q34581503-98A24367-A1EC-4568-AE5E-AA5E4B5AE4CCQ34621525-F61FD79C-F1BD-47D8-B21C-FADF9CD6A155Q35115255-15A0F37D-DEE6-490C-AAAD-D579386F1753Q35119472-238B7AF0-9659-4429-9DA3-7F4F24C94A05Q35137662-281B3982-1281-469A-9C95-29E2FAD3521AQ35328263-975ACF73-49EA-4341-9250-32CE037BA2F3Q35538772-0299FE74-CF7C-43AF-B2E0-608263E6941FQ35542198-164DCEA6-F856-4E88-A3B3-9DBEE96FC7C4Q35640457-9D695ECF-0170-4D87-AE6F-C501B9C85101Q35644246-1F18B416-9C20-40A5-B5D0-7E86540E78F9Q35807882-9A5D9222-7D99-4C05-A117-3B40DEF1E3F8Q35860128-0DEBFC5C-AFDF-44CB-B11A-4D1B4095CEE6Q35884855-502168AA-9E6F-481A-BA7E-626BBA643D8BQ35885383-479F2971-3E27-4309-A001-7AF33A461C69Q36960048-6534341F-CC6E-481A-AD40-C8E82F8366A7Q37267276-56066A1E-3A77-4666-A637-42DDD92FBF0DQ37633338-252AD972-7B44-4C4B-B12F-9C721328ACE2Q37763924-FC6F55F1-9681-48C9-9D2E-B8BCEACFEB59Q38218540-EC4821A0-893E-4EBA-A547-333579ADB4C3Q38640000-1C49BE9A-2F5C-42ED-ADC8-E4325E47FB9FQ38872374-AE6C25DA-76D8-4E57-9B0E-B91CA08F92FFQ39747565-1BF88816-CD5F-43EC-B006-0C3A1275D563Q39764329-3B3C455A-AC00-4FC4-BF71-7CA101ECA0CDQ39779656-8A4AA1AE-8864-40C5-B130-CE5EDA629073Q39780653-22F6F804-5B50-45E4-906F-BC8E43D9094EQ39781719-93E7759B-5EC4-4ADD-9782-ED13305ED19F
P2860
Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase
description
1982 nî lūn-bûn
@nan
1982 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Metabolism of thienamycin and ...... dipeptidase, dehydropeptidase
@ast
Metabolism of thienamycin and ...... dipeptidase, dehydropeptidase
@en
Metabolism of thienamycin and ...... dipeptidase, dehydropeptidase
@nl
type
label
Metabolism of thienamycin and ...... dipeptidase, dehydropeptidase
@ast
Metabolism of thienamycin and ...... dipeptidase, dehydropeptidase
@en
Metabolism of thienamycin and ...... dipeptidase, dehydropeptidase
@nl
prefLabel
Metabolism of thienamycin and ...... dipeptidase, dehydropeptidase
@ast
Metabolism of thienamycin and ...... dipeptidase, dehydropeptidase
@en
Metabolism of thienamycin and ...... dipeptidase, dehydropeptidase
@nl
P2093
P2860
P356
P1476
Metabolism of thienamycin and ...... dipeptidase, dehydropeptidase
@en
P2093
P2860
P356
10.1128/AAC.22.1.62
P407
P577
1982-07-01T00:00:00Z